MediciNova, Inc. (MNOV)
NASDAQ: MNOV · Real-Time Price · USD
1.780
+0.150 (9.20%)
At close: Oct 2, 2026, 4:00 PM EDT
1.920
+0.140 (7.87%)
After-hours: Oct 2, 2026, 7:30 PM EDT
MediciNova Employees
MediciNova had 6 employees as of December 31, 2025. The number of employees decreased by 7 or -53.85% compared to the previous year.
Employees
6
Change (1Y)
-7
Growth (1Y)
-53.85%
Revenue / Employee
$153,414
Profits / Employee
-$1,792,175
Market Cap
87.61M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 6 | -7 | -53.85% |
| Dec 31, 2024 | 13 | 0 | - |
| Dec 31, 2023 | 13 | 0 | - |
| Dec 31, 2022 | 13 | 2 | 18.18% |
| Dec 31, 2021 | 11 | 2 | 22.22% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Fractyl Health | 100 |
| Pelthos Therapeutics | 92 |
| Acrivon Therapeutics | 76 |
| Verrica Pharmaceuticals | 76 |
| ImmuCell | 73 |
| Connect Biopharma Holdings | 64 |
| Oncolytics Biotech | 29 |
| Atara Biotherapeutics | 10 |
MNOV News
- 4 days ago - MediciNova reports results from MN-001-NATG-202 Phase 2 trial of MN-001 - TheFly
- 4 days ago - MediciNova Announces Topline Results from MN-001-NATG-202 Clinical Trial of MN-001 (Tipelukast) - GlobeNewsWire
- 8 days ago - MediciNova completes LPLV in Phase 2b/3 clinical trial evaluating MN-166 - TheFly
- 8 days ago - MediciNova Announces Completion of Last Patient, Last Visit in the Double-Blind Portion of the Phase 2b/3 COMBAT-ALS Trial of MN-166 (Ibudilast) - GlobeNewsWire
- 15 days ago - MediciNova initiated with a Buy at Roth Capital - TheFly
- 21 days ago - MediciNova Transcript: H.C. Wainwright 28th Annual Global Investment Conference - Transcripts
- 24 days ago - MediciNova to Participate in Two Investor Conferences in September - GlobeNewsWire
- 7 weeks ago - MediciNova Quarterly report: Q2 2026 - Filings